LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

Inicio・Lista de Acciones・Codexis Inc

Codexis Inc

Cerrado

SectorSanidad

1.58 -3.66

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.56

Máximo

1.62

Métricas clave
By Trading Economics
Ingresos	29M 9.6M
Ventas	30M 39M
Margen de beneficios	24.672
Empleados	146
EBITDA	33M 17M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+291.57% upside

Dividendos
By Dow Jones
Próximas Ganancias	13 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	33M 146M
Apertura anterior	5.24
Cierre anterior	1.58

Noticias sobre sentimiento de mercado

By Acuity

20%

80%

47 / 349 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

2.25 / 2.53 Soporte y Resistencia

Codexis Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

6 nov 2025, 21:37 UTC

Ganancias

Codexis to Cut About 24% of Workforce

Comparación entre iguales

Cambio de precio

Codexis Inc previsión

Precio Objetivo

By TipRanks

291.57% repunte

Estimación a 12 Meses

Media 6.5 USD 291.57%

Máximo 11 USD

Mínimo 2 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Codexis Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

3 ratings

Comprar

Mantener

Vender

De acuerdo con 3 analistas que ofrecen calificaciones bursátiles a para Codexis Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

2.25 / 2.53Soporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bearish.

Sentimiento

By Acuity

47 / 349 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.